• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Kenneth M. Kaye, MD

Publications

  • Beauchemin C, Moerke NJ, Faloon P, Kaye KM.Assay Development and High-Throughput Screening for Inhibitors of Kaposi's Sarcoma-Associated Herpesvirus N-Terminal Latency-Associated Nuclear Antigen Binding to Nucleosomes.J Biomol Screen. 2014 Feb 11.
    24518064
  • De León Vázquez E, Juillard F, Rosner B, Kaye KM.A short sequence immediately upstream of the internal repeat elements is critical for KSHV LANA mediated DNA replication and impacts episome persistence.Virology. 2014 Jan 5;448:344-55.
    24314665
  • Correia B, Cerqueira SA, Beauchemin C, Pires de Miranda M, Li S, Ponnusamy R, Rodrigues L, Schneider TR, Carrondo MA, Kaye KM, Simas JP, McVey CE.Crystal structure of the gamma-2 herpesvirus LANA DNA binding domain identifies charged surface residues which impact viral latency.PLoS Pathog. 2013;9(10):e1003673.
    24146618
  • Vázquez Ede L, Carey VJ, Kaye KM.Identification of Kaposi's sarcoma-associated herpesvirus LANA regions important for episome segregation, replication, and persistence.J Virol. 2013 Nov;87(22):12270-83.
    24006437
  • Rodrigues L, Popov N, Kaye KM, Simas JP.Stabilization of Myc through heterotypic poly-ubiquitination by mLANA is critical for γ-herpesvirus lymphoproliferation.PLoS Pathog. 2013;9(8):e1003554.
    23950719
  • Habison AC, Beauchemin C, Simas JP, Usherwood EJ, Kaye KM.Murine Gammaherpesvirus 68 LANA Acts on Terminal Repeat DNA To Mediate Episome Persistence.J Virol. 2012 Nov;86(21):11863-76.
    22915819
  • Pogue JM, Potoski BA, Kaye KS.Aminoglycoside use in intensive care units and aminoglycoside nephrotoxicity. Comment letter 1.Antimicrob Agents Chemother. 2010 Jun;54(6):2750, author reply 2751.
    20479210
  • Kelley-Clarke B,De Leon-Vazquez E,Slain K,Barbera AJ,Kaye KM.Role of Kaposi's sarcoma-associated herpesvirus C-terminal LANA chromosome binding in episome persistence.J Virol. 2009 May;83(9):4326-37.
    19225000
  • Chodaparambil JV, Barbera AJ, Lu X, Kaye KM, Hansen JC, Luger K.A charged and contoured surface on the nucleosome regulates chromatin compaction.Nat Struct Mol Biol. 2007 Nov;14(11):1105-7.
    17965723
  • Bihl F, Narayan M, Chisholm JV, Henry LM, Suscovich TJ, Brown EE, Welzel TM, Kaufmann DE, Zaman TM, Dollard S, Martin JN, Wang F, Scadden DT, Kaye KM, Brander C.Lytic and latent antigens of the human gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus induce T-cell responses with similar functional properties and memory phenotypes.J Virol. 2007 May;81(9):4904-8.
    17329344
  • Kelley-Clarke B, Ballestas ME, Srinivasan V, Barbera AJ, Komatsu T, Harris TA, Kazanjian M, Kaye KM.Determination of Kaposi's sarcoma-associated herpesvirus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA binding.J Virol. 2007 Apr;81(8):4348-56.
    17287261
  • Kelley-Clarke B, Ballestas ME, Komatsu T, Kaye KM.Kaposi's sarcoma herpesvirus C-terminal LANA concentrates at pericentromeric and peri-telomeric regions of a subset of mitotic chromosomes.Virology. 2007 Jan 20;357(2):149-57.
    16979209
  • You J, Srinivasan V, Denis GV, Harrington WJ, Ballestas ME, Kaye KM, Howley PM.Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes.J Virol. 2006 Sep;80(18):8909-19.
    16940503
  • Barbera AJ, Chodaparambil JV, Kelley-Clarke B, Luger K, Kaye KM.Kaposi's sarcoma-associated herpesvirus LANA hitches a ride on the chromosome.Cell Cycle. 2006 May;5(10):1048-52.
    16721045
  • Barbera AJ, Chodaparambil JV, Kelley-Clarke B, Joukov V, Walter JC, Luger K, Kaye KM.The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA.Science. 2006 Feb 10;311(5762):856-61.
    16469929
  • Komatsu T, Ballestas ME, Barbera AJ, Kelley-Clarke B, Kaye KM.KSHV LANA1 binds DNA as an oligomer and residues N-terminal to the oligomerization domain are essential for DNA binding, replication, and episome persistence.Virology. 2004 Feb 20;319(2):225-36.
    14980483
  • Barbera AJ, Ballestas ME, Kaye KM.The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 N terminus is essential for chromosome association, DNA replication, and episome persistence.J Virol. 2004 Jan;78(1):294-301.
    14671111
  • Li H, Komatsu T, Dezube BJ, Kaye KM.The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter.J Virol. 2002 Dec;76(23):11880-8.
    12414930
  • Komatsu T, Barbera AJ, Ballestas ME, Kaye KM.The Kaposi' s sarcoma-associated herpesvirus latency-associated nuclear antigen.Viral Immunol. 2001;14(4):311-7.
    11792061
  • Ballestas ME, Kaye KM.Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA.J Virol. 2001 Apr;75(7):3250-8.
    11238851
  • Fisman DN, Kaye KM.Once-daily dosing of aminoglycoside antibiotics.Infect Dis Clin North Am. 2000 Jun;14(2):475-87.
    10829267
  • Ballestas ME, Chatis PA, Kaye KM.Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen.Science. 1999 Apr 23;284(5414):641-4.
    10213686
  • Jones D, Ballestas ME, Kaye KM, Gulizia JM, Winters GL, Fletcher J, Scadden DT, Aster JC.Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient.N Engl J Med. 1998 Aug 13;339(7):444-9.
    9700178
  • Eliopoulos AG, Stack M, Dawson CW, Kaye KM, Hodgkin L, Sihota S, Rowe M, Young LS.Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.Oncogene. 1997 Jun 19;14(24):2899-916.
    9205097
  • Devergne O, Hatzivassiliou E, Izumi KM, Kaye KM, Kleijnen MF, Kieff E, Mosialos G.Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.Mol Cell Biol. 1996 Dec;16(12):7098-108.
    8943365
  • Ansieau S, Scheffrahn I, Mosialos G, Brand H, Duyster J, Kaye K, Harada J, Dougall B, Hbinger G, Kieff E, Herrmann F, Leutz A, Gruss HJ.Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation.Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14053-8.
    8943059
  • Kaye KM, Izumi KM, Mosialos G, Kieff E.The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues.J Virol. 1995 Feb;69(2):675-83.
    7815530
  • Izumi KM, Kaye KM, Kieff ED.Epstein-Barr virus recombinant molecular genetic analysis of the LMP1 amino-terminal cytoplasmic domain reveals a probable structural role, with no component essential for primary B-lymphocyte growth transformation.J Virol. 1994 Jul;68(7):4369-76.
    8207810
  • Kaye KM, Izumi KM, Kieff E.Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9150-4.
    8415670
  • Kaye KM, Spriggs DR, Bassel-Duby R, Fields BN, Tyler KL.Genetic basis for altered pathogenesis of an immune-selected antigenic variant of reovirus type 3 (Dearing).J Virol. 1986 Jul;59(1):90-7.
    3012122